| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |